We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$76.1B
AUM Growth
+$4.53B
(+6.3%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
16.55%
Holding
798
New
67
Increased
286
Reduced
299
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$550M |
| 2 |
Goldman Sachs
GS
|
+$448M |
| 3 |
ConocoPhillips
COP
|
+$390M |
| 4 |
BorgWarner
BWA
|
+$373M |
| 5 |
Marathon Petroleum
MPC
|
+$365M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$545M |
| 2 |
Occidental Petroleum
OXY
|
+$491M |
| 3 |
Verizon
VZ
|
+$433M |
| 4 |
RTN
Raytheon Company
RTN
|
+$266M |
| 5 |
Aon
AON
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.05% |
| 2 | Healthcare | 13.47% |
| 3 | Technology | 12.73% |
| 4 | Energy | 10.48% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCOM
726
DELISTED
Points.com Inc. Common Shares
PCOM
| $590K | ﹤0.01% |
77,200
-19,380
| -20% | -$147K |
|
727
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $551K | ﹤0.01% |
+2,467
| New | +$539K |
|
728
Xcel Energy
XEL
$51B
| $532K | ﹤0.01% |
13,064
+1,191
| +10% | +$47.6K |
|
|
OIIM
729
DELISTED
02Micro International
OIIM
| $528K | ﹤0.01% |
293,400
-177,840
| -38% | -$332K |
|
|
RLOG
730
DELISTED
Rand Logistics, Inc.
RLOG
| $527K | ﹤0.01% |
634,815
-366,660
| -37% | -$313K |
|
731
Pinnacle West Capital
PNW
$12.9B
| $526K | ﹤0.01% |
6,743
+616
| +10% | +$46.2K |
|
|
LVNTA
732
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $502K | ﹤0.01% |
13,614
-9,078
| -40% | -$357K |
|
733
Great Elm Group
GEG
$68.4M
| $450K | ﹤0.01% |
119,981
| – | – |
|
|
WCIC
734
DELISTED
WCI Communities, Inc.
WCIC
| $415K | ﹤0.01% |
17,700
-4,400
| -20% | -$103K |
|
735
CPI Aerostructures
CVU
$62.2M
| $414K | ﹤0.01% |
44,724
-11,330
| -20% | -$83.2K |
|
736
CACI
CACI
$10.8B
| $382K | ﹤0.01% |
3,070
+280
| +10% | +$32.3K |
|
|
LEXEA
737
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $360K | ﹤0.01% |
+9,075
| New | +$385K |
|
738
The Joint Corp
JYNT
$119M
| $358K | ﹤0.01% |
135,100
+19,640
| +17% | +$48.1K |
|
739
TSMC
TSM
$2.09T
| $332K | ﹤0.01% |
11,540
-3,981
| -26% | -$120K |
|
740
Harte-Hanks
HHS
$17.7M
| $295K | ﹤0.01% |
19,510
+3,550
| +22% | +$53.8K |
|
|
CBK
741
DELISTED
Christopher & Banks Corporation
CBK
| $283K | ﹤0.01% |
+121,152
| New | +$207K |
|
742
Telkom Indonesia
TLK
$14.2B
| $241K | ﹤0.01% |
8,272
-2,996
| -27% | -$90.7K |
|
743
SK Telecom
SKM
$13.7B
| $217K | ﹤0.01% |
6,285
-1,367
| -18% | -$48.7K |
|
744
Ambev
ABEV
$47.3B
| $135K | ﹤0.01% |
27,441
-41,946
| -60% | -$226K |
|
|
GZT
745
DELISTED
Gazit-globe Ltd
GZT
| $119K | ﹤0.01% |
13,746
-2,307
| -14% | -$21.2K |
|
746
AbbVie
ABBV
$458B
| – | – |
-1,401,128
| Closed | -$88.4M |
|
747
Ameriprise Financial
AMP
$46.8B
| – | – |
-36,321
| Closed | -$3.62M |
|
748
Builders FirstSource
BLDR
$7.84B
| – | – |
-2,172,662
| Closed | -$25M |
|
749
Chunghwa Telecom
CHT
$33.2B
| – | – |
-8,800
| Closed | -$308K |
|
750
Corcept Therapeutics
CORT
$10.2B
| – | – |
-335,941
| Closed | -$2.18M |
|
Similar funds
Boston Partners's Q4 2016 Portfolio in Review
As of Q4 2016, Boston Partners held 798 positions worth $76.1B, up 6.3% from $71.5B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q4 2016 filing shows 67 new, 286 increased, 299 reduced and 53 closed positions. Its largest new stake was BorgWarner: 11,568,722 shares worth $402M. The largest sale was McKesson, an estimated $545M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q4 2016 buy was BorgWarner: 11,568,722 shares worth $402M.
- Boston Partners added most to Pfizer in Q4 2016, an estimated $550M increase.
- Boston Partners's biggest Q4 2016 reduction was McKesson, cutting an estimated $545M.
- Boston Partners fully exited Valspar in Q4 2016, selling an estimated $177M.
- Boston Partners's ten largest holdings make up 17% of its $76.1B portfolio in Q4 2016.
- Boston Partners opened 67 new positions and closed 53 in Q4 2016.
- Boston Partners's portfolio value rose 6.3% quarter-over-quarter to $76.1B.
Based on Boston Partners's 13F filing for Q4 2016, filed 6 Feb 2017.